




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Diabetes and Cardiometabolic Disease</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=d4ccb5f4-249c-45f4-8f48-d8ecbcf86a58</link>
        <description>Clinical Topic Feed: Diabetes and Cardiometabolic Disease</description>
        <language>en</language>

        

                <item>
                    <title>Rising HDP Rates in the US; BP Monitoring Across the Lifespan</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Rising-HDP-Rates-in-the-US</link>                    <description>The rate of new-onset hypertensive disorders of pregnancy (HDP) in the U.S. increased significantly from 2016 to 2024 across all racial and ethnic groups, according to a brief JACC report &#226;€“ the importance of which is further echoed in a longer systematic review of blood pressure (BP) monitoring across a patient&#39;s lifespan published in JACC&#39;s May 12 hypertension focus issue.</description>
                    <pubdate>1778688120000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Evolocumab Cuts Risk in Absence of ASCVD: Sotatercept For CpCPH, HFpEF</title>
<link>/Latest-in-Cardiology/Articles/2026/05/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1777637340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Preventing Pregnancy-Related CVD and Maternal Mortality in the US</title>
<link>/Latest-in-Cardiology/Articles/2026/04/30/10/29/Preventing-Pregnancy-Related-CVD</link>                    <description>A new report from the National Academies of Sciences, Engineering, and Medicine calls for &quot;stronger clinical preventive services, better follow-up after delivery, and improved care coordination across the reproductive life course&quot; to better manage cardiovascular disease risk in pregnant and postpartum patients...</description>
                    <pubdate>1777573140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Heart Failure Trials Featured at ACC.26</title>
<link>/Latest-in-Cardiology/Articles/2026/04/27/19/07/Heart-Failure-Trials-Featured-at-ACC26</link>                    <description>ACC.26 featured several late-breaking heart failure clinical trials, including two focused on subgroups of heart failure that until now had limited data to guide therapies.</description>
                    <pubdate>1777460220000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Is ApoB an Appropriate Cost-Effective Marker For Lipid-Lowering Therapy?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/17/16/45/ApoB Appropriate</link>                    <description>Apolipoprotein B (apoB) may be used as a cost-effective marker to improve population health and guide lipid-lowering therapy (LLT) in primary prevention, according to a computer simulation study published April 8 in JAMA.</description>
                    <pubdate>1776445740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Addressing Cardiovascular-Kidney-Metabolic Syndrome Health</title>
<link>/Latest-in-Cardiology/Articles/2026/04/14/14/19/accel-lite-14apr2026</link>                    <description>In this interview, Alison L. Bailey, MD, FACC and&#226;€&#175; Chiadi E. Ndumele, MD, PhD discuss Addressing Cardiovascular-Kidney-Metabolic Syndrome Health.</description>
                    <pubdate>1776178140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Editors&#39; Corner | Proven, Practical, Patient First: Turning Research Into Results</title>
<link>/Latest-in-Cardiology/Articles/2026/04/01/01/Editors-Corner-Proven-Practical-Patient-First</link>                    <description>This issue brings together a set of stories united by a central theme familiar to every cardiologist: how high&#226;€‘quality evidence becomes high&#226;€‘value care. From prevention in childhood to advanced interventions for complex disease, each story in these pages reflects a different point along the continuum of heart health &#226;€“ yet all focus on turning research into meaningful, practical action.</description>
                    <pubdate>1775046000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Journal Wrap | Renal Function Change and Post M-TEER Survival; Pregnancy Biomarkers and CV Risk; More</title>
<link>/Latest-in-Cardiology/Articles/2026/04/01/01/Journal-Wrap</link>                    <description>The hottest research from various peer-reviewed journals &#226;€“ handpicked weekly by the ACC.</description>
                    <pubdate>1775045400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Number Check | HOT OFF THE PRESSES: New Clinical Guideline For Managing Dyslipidemia</title>
<link>/Latest-in-Cardiology/Articles/2026/04/01/01/Number-Check-New-Clinical-Guideline-Dyslipidemia</link>                    <description>The new ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive &quot;one-stop shop&quot; for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia and elevated lipoprotein(a).</description>
                    <pubdate>1775045280000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Essence-CTA: Does Olezarsen Reduce Noncalcified Coronary Plaque Volume?</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/mon-830am-essence-acc-2026</link>                    <description>In patients with moderate hypertriglyceridemia, significant reductions in triglyceride and remnant cholesterol levels with olezarsen, on top of standard-of-care lipid-lowering therapy, did not translate into a significant change from baseline in noncalcified coronary plaque volume (NCPV), according to results from Essence-CTA, a substudy of the Essence-TIMI 73b trial, presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans and simultaneously published in Circulation.</description>
                    <pubdate>1774877580000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>